Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 46.79 -3.66% -1.78
AXSM closed down 3.66 percent on Friday, December 13, 2019, on 1.28 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
See historical AXSM trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup -3.66%
Wide Bands Range Expansion -3.66%
Overbought Stochastic Strength -3.66%
Calm After Storm Range Contraction -2.66%
NR7 Range Contraction -2.66%
New 52 Week High Strength -2.66%
Wide Bands Range Expansion -2.66%
Older signals for AXSM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Medicine Pain Organ Systems Alzheimer's Disease Pain Management Osteoarthritis Chronic Pain Central Nervous System Disorders Perception Antidepressants Back Pain Chronic Condition Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.0
52 Week Low 1.94
Average Volume 998,602
200-Day Moving Average 23.31
50-Day Moving Average 29.36
20-Day Moving Average 39.83
10-Day Moving Average 45.86
Average True Range 2.99
ADX 47.68
+DI 32.92
-DI 12.26
Chandelier Exit (Long, 3 ATRs ) 41.04
Chandelier Exit (Short, 3 ATRs ) 33.11
Upper Bollinger Band 53.71
Lower Bollinger Band 25.94
Percent B (%b) 0.75
BandWidth 69.72
MACD Line 5.61
MACD Signal Line 5.22
MACD Histogram 0.3856
Fundamentals Value
Market Cap 1.1 Billion
Num Shares 23.6 Million
EPS -1.45
Price-to-Earnings (P/E) Ratio -32.27
Price-to-Sales 0.00
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 53.67
Resistance 3 (R3) 53.97 51.97 52.52
Resistance 2 (R2) 51.97 50.22 51.82 52.14
Resistance 1 (R1) 49.38 49.13 48.38 49.08 51.76
Pivot Point 47.38 47.38 46.88 47.23 47.38
Support 1 (S1) 44.79 45.63 43.79 44.50 41.82
Support 2 (S2) 42.79 44.55 42.65 41.44
Support 3 (S3) 40.21 42.79 41.06
Support 4 (S4) 39.91